What is the official website of MSD Deutschland ?

The official website of MSD Deutschland is https://www.msd.de/impressum/.

What is MSD Deutschland's cybersecurity risk score?

MSD Deutschland has an AI-generated cybersecurity risk score of 761 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has MSD Deutschland experienced?

According to Rankiteo, MSD Deutschland currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has MSD Deutschland been affected by any supply chain cyber incidents ?

According to Rankiteo, MSD Deutschland has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does MSD Deutschland have SOC 2 Type 1 certification ?

According to Rankiteo, MSD Deutschland is not certified under SOC 2 Type 1.

Does MSD Deutschland have SOC 2 Type 2 certification ?

According to Rankiteo, MSD Deutschland does not hold a SOC 2 Type 2 certification.

Does MSD Deutschland comply with GDPR ?

According to Rankiteo, MSD Deutschland is not listed as GDPR compliant.

Does MSD Deutschland have PCI DSS certification ?

According to Rankiteo, MSD Deutschland does not currently maintain PCI DSS compliance.

Does MSD Deutschland comply with HIPAA ?

According to Rankiteo, MSD Deutschland is not compliant with HIPAA regulations.

Does MSD Deutschland have ISO 27001 certification ?

According to Rankiteo,MSD Deutschland is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does MSD Deutschland operate in ?

MSD Deutschland operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does MSD Deutschland have ?

MSD Deutschland employs approximately 1,982 people worldwide.

Does MSD Deutschland own any subsidiaries ?

MSD Deutschland presently has no subsidiaries across any sectors.

How many LinkedIn followers does MSD Deutschland have ?

MSD Deutschland's official LinkedIn profile has approximately 44,605 followers.

What is the NAICS classification code for MSD Deutschland ?

MSD Deutschland is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does MSD Deutschland have a Crunchbase profile ?

No, MSD Deutschland does not have a profile on Crunchbase.

Does MSD Deutschland have a LinkedIn profile ?

Yes, MSD Deutschland maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/msd-deutschland.

How many cybersecurity incidents has MSD Deutschland experienced ?

As of September 24, 2026, Rankiteo reports that MSD Deutschland has experienced 1 cybersecurity incidents.

How many peer or competitor companies does MSD Deutschland have ?

MSD Deutschland has an estimated 5,769 peer or competitor companies worldwide.

What types of cybersecurity incidents has MSD Deutschland faced ?

Incident Types: The types of cybersecurity incidents that have occurred include Breach.

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

MSD Deutschland

Boost Score +25 with badge (5 left)

761

/1000

Fair

786

/1000

Fair

MSD Deutschland Vendor Cyber Rating & Cyber Score

msd.de

Add Your Compliance Badge

Bei MSD, in den USA und Kanada bekannt als Merck & Co., Inc., Rahway, NJ, USA, eint uns ein Ziel: Wir nutzen führende wissenschaftliche Erkenntnisse, um auf der ganzen Welt Leben zu retten und mehr Lebensqualität zu ermöglichen. Bereits seit über 130 Jahren stehen wir durch die Entwicklung wichtiger neuer Medikamente und Impfstoffe für Fortschritt. Unser Anspruch ist es, als forschendes biopharmazeutisches Unternehmen global führend zu sein – und wir entwickeln innovative Gesundheitslösungen und Wirkstoffe, die die Prävention und Behandlung von Krankheiten bei Menschen und Tieren weiter verbessern. Wir fördern Vielfalt und Inklusion in unseren Teams weltweit und handeln jeden Tag verantwortungsbewusst, um allen Menschen eine sichere,

MSD Deutschland

MSD Deutschland CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

MSD Deutschland

Breach

9/2025

MSD060270611182...

Loading…

A.I.

MSD Deutschland Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for MSD Deutschland

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for MSD Deutschland in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for MSD Deutschland in 2026.

Incident Types MSD Deutschland vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for MSD Deutschland in 2026.

Incident History - MSD Deutschland (X = Date, Y = Severity)

Loading…

SUBSIDIARY

MSD Deutschland Subsidiaries

MSD Deutschland

Pharmaceutical Manufacturing

Website: https://www.msd.de/impressum/

Company Size: 1,001-5,000 employees

MSDPharmaceutical Manufacturing

MSD FrancePharmaceutical Manufacturing

MSD Saúde AnimalVeterinary Services

MSD EspañaPharmaceutical Manufacturing

MSD Animal HealthPharmaceutical Manufacturing

MSD EgyptPharmaceutical Manufacturing

MSD PortugalPharmaceutical Manufacturing

MSD LATAMPharmaceutical Manufacturing

MSD NetherlandsPharmaceutical Manufacturing

MSD GCCPharmaceutical Manufacturing

MSD SwitzerlandPharmaceutical Manufacturing

MSD Animal Health Technology LabsTechnology, Information and Internet

MSD TürkiyePharmaceutical Manufacturing

MSD ItaliaPharmaceutical Manufacturing

MSD GreecePharmaceutical Manufacturing

MSD South AfricaPharmaceutical Manufacturing

MSD Australia & New ZealandPharmaceutical Manufacturing

MSD BelgiumPharmaceutical Manufacturing

MSD in the UKPharmaceutical Manufacturing

MSD Czech RepublicPharmaceutical Manufacturing

MSD JordanPharmaceutical Manufacturing

MSD RomaniaPharmaceutical Manufacturing

MSD ÖsterreichPharmaceutical Manufacturing

MSD PolskaPharmaceutical Manufacturing

MSD Animal Health UK LtdPharmaceutical Manufacturing

MSD LebanonPharmaceutical Manufacturing

MSD DanmarkPharmaceutical Manufacturing

MSD SverigePharmaceutical Manufacturing

MSD FinlandPharmaceutical Manufacturing

MSD NorgePharmaceutical Manufacturing

MSD SRBIJAPharmaceutical Manufacturing

MSD MagyarországPharmaceutical Manufacturing

MSD SlovenskoPharmaceutical Manufacturing

MSD UkrainePharmaceutical Manufacturing

Loading…

MSD Deutschland Similar Companies

AUROBINDO PHARMA LTD

aurobindo.com

Aurobindo Pharma Limited (NSE: AUROPHARMA, BSE: 524804, Reuters: ARBN.NS, Bloomberg: ARBP IN) is an integrated global pharmaceutical company headquartered in Hyderabad, India. The Company develops, manufactures, and markets a wide range of generic pharmaceuticals, branded specialty drugs, and active pharmaceutical ingredients (APIs) across more than 150 countries. It is ranked among the top 10 generic companies in eight European nations and holds the distinction of being the largest generic pharmaceutical company in the United States. With over 30 state-of-the-art manufacturing and packaging facilities approved by leading global regulatory authorities including USFDA, UK MHRA, EDQM, Japan PMDA, WHO, Health Canada, South Africa MCC, and Brazil ANVISA, Aurobindo Pharma ensures the highest standards of quality. Its robust portfolio spans eight major therapeutic areas: Central Nervous System (CNS), Antiretroviral (ARV), Cardiovascular (CVS), Antibiotics, Gastroenterology, Anti-diabetics, Oncology, and Dermatology, supported by a strong R&D infrastructure that drives innovation, affordability, and accessibility.

Merck Group

merckgroup.com

This channel is not intended for U.S. and Canadian visitors. Merck operates in the U.S. and Canada as EMD Serono in Healthcare, MilliporeSigma in Life Science and EMD Electronics in Electronics. An unaffiliated and unrelated company, Merck & Co., Inc., Kenilworth, NJ, US holds the rights in the trademark MERCK in the U.S. and Canada. _______________________________ We are Merck, a leading global science and technology company headquartered in Germany. We are curious explorers, courageous pioneers, and ingenious inventors. Our colleagues across the globe love innovating with science and technology to enrich people’s lives with our solutions in Life Science, Healthcare, and Electronics. Together, we dream big and are passionate about caring for our rich mix of people, customers, patients, and the planet. We believe in the positive power of science and technology. It has determined our actions since 1668 and inspires us to continue researching for a future worth living. As a family-owned company with over 350 years of experience, we stand for sustainability, responsibility, and innovative strength. We take pride in being a diverse and inclusive company that values and fosters the talents and abilities of our employees. That's why we are always looking for curious minds that see themselves imagining the unimaginable with us. Work your Magic and join Merck. Legal Disclaimer: www.merckgroup.com/en/legal-disclaimer.html Data Privacy Declaration: www.merckgroup.com/en/privacy-statement

Lonza

lonza.com

Lonza is a pioneer and world leader in the CDMO industry, setting the pace with cutting-edge science, smart technology, and lean manufacturing. United by a common purpose, we turn our customers’ breakthrough innovations into viable therapies and manufacture the medicines of tomorrow. Founded in Switzerland in 1897, our company is the first and original CDMO, and today we are more dynamic, agile and forward-focused than ever before. As one of the largest Western CDMOs, we bring together a global team of around 18,500 colleagues across five continents to deliver comprehensive, integrated solutions for our customers' complex needs. For our customers and their patients, we bring quality, safety and reliability to bring life-enhancing and life-saving treatments to market at speed and at scale. For our colleagues, we strive to create a sense of belonging and inclusion where every person can thrive and bring their best.

Alkem Laboratories Ltd.

alkemlabs.com

A single idea, which sprouts from a human mind, contains the potential to create marvels that can influence generations. It can redefine rules, it can transform the world. Back in the year 1973, a team of individuals came with such an idea – The idea called Alkem. It was highly potent and resilient, like a spark that could ignite a thousand more ideas. And it did! Looking back at our 4 decade, illustrious journey, that one small idea has Not only triggered us to become one of India’s largest generic and specialty pharmaceutical company but also, create a foothold in over 50 countries 32% of our revenue is generated via offshore sales. As well as we have consistently been ranked amongst the top ten pharmaceutical companies in India. Our portfolio includes illustrious brands like Clavam, Pan, Pan-D and Taxim-O, which feature amongst top 50 pharmaceutical brands in India. For over a decade, our dominance in anti-infective segment has remained unchallenged. We have 21 manufacturing facilities at multiple locations in India and the United States of America. Our upper-crest facilities are inspected and audited as per cGMP guidelines as laid down by leading regulatory authorities such as USFDA, MHRA - UK, SAHPRA-South Africa, TGA - Australia, ANVISA - Brazil, WHO - Geneva, TPD - Health Canada, PPB - Kenya, NDA - Uganda, MOH - Sudan, INVIMA - Colombia, TFDA - Tanzania, Zimbabwe, BfArM-Germany & Other Africa, Asian & CIS Countries. Another feather in our cap was added on December 23rd, 2015, when, Alkem completed it's Initial Public Offering (IPO) and was listed on the Bombay Stock Exchange Limited and the National Stock Exchange of India Limited. Although passion is the fuel that keeps ideas alive, innovation is the catalyst that gives it flight! With over 500 scientists working in 5 global R&D centers, we are empowering innovations that align with our philosophy of ‘Extended Lifecare Beyond Boundaries’.

Astellas Pharma

astellas.com

Astellas is a global life sciences company committed to turning innovative science into VALUE for patients. We provide transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health. Through our research and development programs, we are pioneering new healthcare solutions for diseases with high unmet medical need. Visit our Global Astellas LinkedIn Community Guidelines to learn more about interacting with this page: https://www.astellas.com/en/global-linkedin-community-guidelines

Cipla

cipla.com

Cipla is a leading global pharmaceutical company trusted by healthcare professionals and patients across the world since 1935. A compassionate approach to healthcare that goes beyond the pursuit of profit and growth has been the force impelling Cipla’s history over the years. Our credo and our purpose of ‘Caring for Life' continues to guide our actions towards our people and the planet for creating a sustainable future. Cipla today has presence in 80+ countries, providing over 1,500 products across various therapeutic categories in 50+ dosage forms. Keeping with our legacy of care, we constantly strive to ensure access to high-quality medicines that make a difference in the lives of patients. Our paradigm-changing offer of a triple anti-retroviral (ARV) therapy in HIV/AIDS at less than a dollar a day in Africa in 2001 was pivotal in bringing inclusiveness, accessibility and affordability to the centre of the HIV movement. An unmatched presence across the care continuum (awareness, prevention, diagnosis, treatment and adherence) and the widest range of drug-device combinations has established Cipla’s respiratory leadership in India and other key emerging markets. Armed with this legacy and a deep understanding of the lungs, we have articulated our aspiration to become a global lung leader and help millions breathe free.

Sanofi

sanofi.com

We are an R&D driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. We apply our deep understanding of the immune system to invent medicines and vaccines that treat and protect millions of people around the world, with an innovative pipeline that could benefit millions more. Our team is guided by one purpose: we chase the miracles of science to improve people’s lives; this inspires us to drive progress and deliver positive impact for our people and the communities we serve, by addressing the most urgent healthcare, environmental, and societal challenges of our time. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms

AbbVie

cb abbvie.com

AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, aesthetics and other areas of unmet need. Learn more about us at www.abbvie.com and review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html.

MACLEODS PHARMACEUTICALS LTD.

macleodspharma.com

A vertically integrated, Global Pharmaceutical Company. Established in 1989, we are engaged in developing, manufacturing, and marketing a wide range of formulations across several major therapeutic areas including anti-infectives, cardiovascular, anti-diabetic, dermatology, and hormone treatment. We develop, manufacture, and globally distribute a broad range of pharmaceutical products across therapies in multiple dosage forms such as solid orals, liquid orals, topical formulations, injectables (Dry Powder) metered dose inhalers and dry powder inhalers. Our Vision To be a leading global pharmaceutical company by providing high quality, affordable and innovative therapeutic solutions for patients with diverse medical needs. Our Mission To contribute towards improving patients’ quality of life across the globe, by providing effective and accessible medicines.

Loading…

NEWS

MSD Deutschland CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

October 26, 2023 04:30 PM

AI-Powered CRM and ERP Solutions | Microsoft Dynamics 365

Enter the era of AI-powered business with Dynamics 365—CRM and ERP business applications that connect your teams, processes, and data.

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-96680

SUMMARY

A vulnerability was detected in ByteDance Coze Scraper Extension up to 2.0.2. Affected by this vulnerability is the function chrome.runtime.onMessageExternal.addListener of the file static/background/index.js of the component External Message Handler. The manipulation of the argument body.url/paginationConfig/xPathConfig/body.urls/xPaths results in missing authorization. The attack can be launched remotely. The exploit is now public and may be used. The vendor was contacted early about this disclosure but did not respond in any way.

Published

Date2026-09-23

Updated

Date2026-09-23

RISK INFORMATION (Score: 4.3)

cvss2

Base Score: 5.0

Complexity: LOW

AV:N/AC:L/Au:N/C:P/I:N/A:N

cvss3

Base Score: 4.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:N/A:N

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

2.8

REFERENCES

CVE-2026-96678

SUMMARY

A security vulnerability has been detected in weiqingwen spring-boot-forum up to 538eecc3c6b85fdf0768ab4e8354b48c0c17d94f. Affected is the function validate of the file src/main/java/com/qingwenwei/util/NewUserFormValidator.java of the component Avatar Upload. The manipulation of the argument Username leads to path traversal. The attack can be initiated remotely. The exploit has been disclosed publicly and may be used. Continious delivery with rolling releases is used by this product. Therefore, no version details of affected nor updated releases are available. The vendor was contacted early about this disclosure but did not respond in any way.

Published

Date2026-09-23

Updated

Date2026-09-23

RISK INFORMATION (Score: 6.3)

cvss2

Base Score: 6.5

Complexity: LOW

AV:N/AC:L/Au:S/C:P/I:P/A:P

cvss3

Base Score: 6.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

2.8

REFERENCES

CVE-2026-96676

SUMMARY

A vulnerability was identified in Fast FAC1900R 20190827_2.0.2. The impacted element is the function get_alias_name of the component uhttpd. Such manipulation leads to stack-based buffer overflow. The attack may be performed from remote. The exploit is publicly available and might be used. The vendor was contacted early about this disclosure but did not respond in any way.

Published

Date2026-09-23

Updated

Date2026-09-23

RISK INFORMATION (Score: 6.3)

cvss2

Base Score: 6.5

Complexity: LOW

AV:N/AC:L/Au:S/C:P/I:P/A:P

cvss3

Base Score: 6.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

2.8

REFERENCES

CVE-2026-96606

SUMMARY

A security flaw has been discovered in LB-Link BL-CPE600EU 5.8.13. This vulnerability affects unknown code of the file Mifi_config.bin of the component Configuration Backup Handler. The manipulation results in information disclosure. The attack can be launched remotely. The exploit has been released to the public and may be used for attacks. The vendor was contacted early about this disclosure but did not respond in any way.

Published

Date2026-09-23

Updated

Date2026-09-23

RISK INFORMATION (Score: 5.3)

cvss2

Base Score: 5.0

Complexity: LOW

AV:N/AC:L/Au:N/C:P/I:N/A:N

cvss3

Base Score: 5.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N

cvss4

Base Score: 5.5

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

3.9

REFERENCES

CVE-2026-70125

SUMMARY

Microsoft Outlook Remote Code Execution Vulnerability

Published

Date2026-09-23

Updated

Date2026-09-23

RISK INFORMATION (Score: 8.8)

cvss3

Base Score: 8.8

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H

Impact Score

5.9

Exploitability

2.8

REFERENCES

https://msrc.microsoft.com/update-guide/vulnerability/CVE-2026-70125

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…

Badge your company to reduce your risk score and your cyber insurance costs!

Trusted by insurers. Chosen by leaders.

MSD Deutschland Vendor Cyber Rating & Cyber Score

MSD Deutschland A.I CyberSecurity Scoring

MSD Deutschland CyberSecurity News & History

MSD Deutschland Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for MSD Deutschland

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types MSD Deutschland vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - MSD Deutschland (X = Date, Y = Severity)

MSD Deutschland Subsidiaries

MSD Deutschland

MSD Deutschland Similar Companies

AUROBINDO PHARMA LTD

Merck Group

Lonza

Alkem Laboratories Ltd.

Astellas Pharma

Cipla

Sanofi

AbbVie

MACLEODS PHARMACEUTICALS LTD.

MSD Deutschland CyberSecurity News

AI-Powered CRM and ERP Solutions | Microsoft Dynamics 365

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo

MSD Deutschland CyberSecurity News & History

MSD Deutschland Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for MSD Deutschland

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types MSD Deutschland vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - MSD Deutschland (X = Date, Y = Severity)

MSD Deutschland Subsidiaries

MSD Deutschland

MSD Deutschland Similar Companies

AUROBINDO PHARMA LTD

Merck Group

Lonza

Alkem Laboratories Ltd.

Astellas Pharma

Cipla

Sanofi

AbbVie

MACLEODS PHARMACEUTICALS LTD.

MSD Deutschland CyberSecurity News

AI-Powered CRM and ERP Solutions | Microsoft Dynamics 365

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo